Clinical calculator based on clinicopathological characteristics predicts local recurrence and overall survival following radical resection of stage II-III colorectal cancer

被引:0
|
作者
Huang, Fei [1 ]
Wei, Ran [2 ]
Mei, Shiwen [1 ]
Xiao, Tixian [1 ]
Zhao, Wei [1 ]
Zheng, Zhaoxu [1 ]
Liu, Qian [1 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Natl Clin Res Ctr Canc, Natl Canc Ctr, Dept Colorectal Surg,Canc Hosp, Beijing, Peoples R China
[2] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Gastrointestinal Surg, Guangzhou, Guangdong, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2025年 / 15卷
关键词
colorectal cancer; nomogram; clinical risk factor; prognosis; local recurrence; COLON-CANCER; RECTAL-CANCER; CURATIVE RESECTION; ADJUVANT THERAPY; MANAGEMENT; SURGERY; FLUOROURACIL; PATTERNS; OUTCOMES;
D O I
10.3389/fonc.2025.1494255
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose This study aimed to analyze the risk factors and survival prognosis of local recurrence in stage II-III colorectal cancer (CRC) and develop a clinical risk calculator and nomograms to predict local recurrence and survival in treated patients.Methods Patients who underwent radical surgery between January 2009 and December 2019 at the China National Cancer Center were included. Multivariate nomograms and a clinical risk calculator based on Cox regression were developed. Discrimination was measured with an area under curve (AUC) and variability in individual predictions was assessed with calibration curves. We stratified patients into different risk groups according to the established model to predict their prognosis and guide clinical practice.Results The clinical risk calculator incorporated six variables: tumor thrombus, perineural invasion, tumor grade, pathology T-stage, pathology N-stage, and whether more than 12 lymph nodes were harvested. Our clinical risk calculator provided good discrimination, with AUC values of local recurrence-free survival (LRFS) (0.764) and overall survival (OS) (0.815) in the training cohort and LRFS (0.740) and OS (0.730) in the test cohort. Calibration plots illustrated excellent agreement between the clinical risk calculator predictions and actual observations for 3- and 5-year LRFS and OS. Recurrence risk-stratified analysis showed that low-risk patients were more likely to undergo salvage radical surgery when recurrent disease existed.Conclusion The clinical calculator can better account for tumor and patient heterogeneity, providing a more individualized outcome prognostication. The model is expected to aid in treatment planning, such as resectability evaluation, and it can be used in postoperative surveillance (https://oldcoloncancer.shinyapps.io/dynnomapp/).
引用
收藏
页数:12
相关论文
共 50 条
  • [41] Multicenter, phase II clinical trial of peptide vaccination with oral chemotherapy following curative resection for stage III colorectal cancer
    Kawamura, Junichiro
    Sugiura, Fumiaki
    Sukegawa, Yasushi
    Yoshioka, Yasumasa
    Hida, Jin-Ichi
    Hazama, Shoichi
    Okuno, Kiyotaka
    ONCOLOGY LETTERS, 2018, 15 (04) : 4241 - 4247
  • [42] A Prediction Model for Tumor Recurrence in Stage II-III Colorectal Cancer Patients: From a Machine Learning Model to Genomic Profiling
    Chen, Po-Chuan
    Yeh, Yu-Min
    Lin, Bo-Wen
    Chan, Ren-Hao
    Su, Pei-Fang
    Liu, Yi-Chia
    Lee, Chung-Ta
    Chen, Shang-Hung
    Lin, Peng-Chan
    BIOMEDICINES, 2022, 10 (02)
  • [43] ACCENT-Based Web Calculators to Predict Recurrence and Overall Survival in Stage III Colon Cancer
    Renfro, Lindsay A.
    Grothey, Axel
    Xue, Yuan
    Saltz, Leonard B.
    Andre, Thierry
    Twelves, Chris
    Labianca, Roberto
    Allegra, Carmen J.
    Alberts, Steven R.
    Loprinzi, Charles L.
    Yothers, Greg
    Sargent, Daniel J.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2014, 106 (12):
  • [44] Overall survival and clinical characteristics of BRCA mutation carriers with stage I/II pancreatic cancer
    Golan, Talia
    Sella, Tal
    O'Reilly, Eileen M.
    Katz, Matthew H. G.
    Epelbaum, Ron
    Kelsen, David P.
    Borgida, Ayelet
    Maynard, Hannah
    Kindler, Hedy
    Friedmen, Eitan
    Javle, Milind
    Gallinger, Steven
    BRITISH JOURNAL OF CANCER, 2017, 116 (06) : 697 - 702
  • [45] Overall survival and clinical characteristics of BRCA mutation carriers with stage I/II pancreatic cancer
    Talia Golan
    Tal Sella
    Eileen M O'Reilly
    Matthew H G Katz
    Ron Epelbaum
    David P Kelsen
    Ayelet Borgida
    Hannah Maynard
    Hedy Kindler
    Eitan Friedmen
    Milind Javle
    Steven Gallinger
    British Journal of Cancer, 2017, 116 : 697 - 702
  • [46] Systemic Inflammation After Radiation Predicts Locoregional Recurrence, Progression, and Mortality in Stage II-III Triple-Negative Breast Cancer
    Sherry, Alexander D.
    von Eyben, Rie
    Newman, Neil B.
    Gutkin, Paulina
    Mayer, Ingrid
    Horst, Kathleen
    Chakravarthy, A. Bapsi
    Rafat, Marjan
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (01): : 268 - 276
  • [47] Proto-oncogene HRAS transcript level and overall survival in stage II and III colorectal cancer.
    Kim, Donghyun
    Sharif, Saima
    Garay, Juan Antonio Raygoza
    Churchman, Michelle L.
    Rounbehler, Robert J.
    Bhakta, Avinash S.
    Boland, Patrick M.
    Cavnar, Michael J.
    Hatoum, Hassan
    Huang, Lyen C.
    Kim, Joseph
    Kim, Richard D.
    Lentz, Robert William
    Mukherjee, Sarbajit
    O'Donnell, Mary
    Quartey, Benjamin
    Reilley, Matthew
    Salhia, Bodour
    Schneider, Bryan P.
    Chan, Carlos H. F.
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 231 - 231
  • [48] Effect of Prophylactic Radiotherapy on Patients with Stage II-III Esophageal Cancer after Esophageal Cancer Radical Operation and Influencing Factors in Its Recurrence
    Guo, Dan
    Zheng, Kang
    JOURNAL OF ONCOLOGY, 2021, 2021
  • [49] Survival following recurrence in stage II and III colon cancer:: Findings from the ACCENT data set
    O'Connell, Michael J.
    Campbell, Megan E.
    Goldberg, Richard M.
    Grothey, Axel
    Seitz, Jean-Francois
    Benedetti, Jacqueline K.
    Andre, Thierry
    Haller, Daniel G.
    Sargent, Daniel J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (14) : 2336 - 2341
  • [50] The clinical impact of intraoperative bleeding on peritoneal recurrence after surgery for stage II to III colorectal cancer
    Furukawa, Shunsuke
    Hiraki, Masatsugu
    Kimura, Naoya
    Okuyama, Keiichiro
    Kohya, Naohiko
    Sakai, Masashi
    Kawaguchi, Atsushi
    Ikubo, Akashi
    Samejima, Ryuichiro
    ASIAN JOURNAL OF SURGERY, 2025, 48 (01) : 363 - 369